Cite
HARVARD Citation
Klahan, S. et al. (n.d.). Gene expression profiling combined with functional analysis identify integrin beta1 (ITGB1) as a potential prognosis biomarker in triple negative breast cancer. Pharmacological research. pp. 31-37. [Online].